Skip to main content
Journal cover image

Outcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support.

Publication ,  Journal Article
Alvarez, A; Dewan, KC; Milano, CA; Jawitz, OK; Benkert, AR; Olive, JK; Berryan, A; Peralta, I; Patel, CB; Agarwal, R; DeVore, AD; McCartney, S ...
Published in: J Thorac Cardiovasc Surg
October 9, 2025

OBJECTIVE: To evaluate characteristics and outcomes of patients bridged to orthotopic heart transplantation with microaxial left ventricular assist device (ma-LVAD) versus durable LVAD (d-LVAD). METHODS: This was a single-center retrospective cohort study in which characteristics outcomes of patients undergoing orthotopic heart transplantation between May 2019 and May 2024 who were bridged with ma-LVAD versus d-LVAD, were compared. RESULTS: Over the study period, the percentage of patients bridged with ma-LVAD increased from 0% to 20%. Patients bridged with d-LVAD were more likely to have history of hypertension (80% vs 65%; P = .03), a higher body mass index (32.53 vs 28.15; P < .0001), and anti-human leukocyte antigens antibodies (54% vs 36%; P = .02) before transplant, otherwise groups were similar in their baseline characteristics. Unadjusted Kaplan-Meier analysis demonstrated no difference in survival between these 2 bridging strategies. However, postoperative blood product use (3 vs 0 units; P < .0001), moderate or severe primary graft dysfunction (27% vs 14%; P = .04), and delayed sternal closure (45% vs 9%; P < .0001) were all higher among those bridged with d-LVAD versus ma-LVAD. Rejection on the first postoperative biopsy was reported in a 60% in the d-LVAD group versus 33% in the ma-LVAD group (P = .0006). Postoperative intensive care unit (7 vs 6 days; P = .03) and overall postoperative length of stay (17 vs 12 days; P = .002) were greater in patients bridged with d-LVAD versus ma-LVAD, respectively. CONCLUSIONS: The use of ma-LVAD compared with d-LVAD as a bridging strategy was not associated with differences in survival. However, bridging with ma-LVAD compared with d-LVAD was associated with lower morbidity after orthotopic heart transplantation.

Duke Scholars

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

October 9, 2025

Location

United States

Related Subject Headings

  • Respiratory System
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alvarez, A., Dewan, K. C., Milano, C. A., Jawitz, O. K., Benkert, A. R., Olive, J. K., … Keenan, J. E. (2025). Outcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support. J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2025.09.050
Alvarez, Alejandro, Krish C. Dewan, Carmelo A. Milano, Oliver K. Jawitz, Abigail R. Benkert, Jacqueline K. Olive, Allison Berryan, et al. “Outcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support.J Thorac Cardiovasc Surg, October 9, 2025. https://doi.org/10.1016/j.jtcvs.2025.09.050.
Alvarez A, Dewan KC, Milano CA, Jawitz OK, Benkert AR, Olive JK, et al. Outcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support. J Thorac Cardiovasc Surg. 2025 Oct 9;
Alvarez, Alejandro, et al. “Outcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support.J Thorac Cardiovasc Surg, Oct. 2025. Pubmed, doi:10.1016/j.jtcvs.2025.09.050.
Alvarez A, Dewan KC, Milano CA, Jawitz OK, Benkert AR, Olive JK, Berryan A, Peralta I, Patel CB, Agarwal R, DeVore AD, McCartney S, Schroder JN, Keenan JE. Outcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support. J Thorac Cardiovasc Surg. 2025 Oct 9;
Journal cover image

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

October 9, 2025

Location

United States

Related Subject Headings

  • Respiratory System
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology